Press release
Osteoarthritis Therapeutics Market was valued at $8.6 billion in 2023 and is projected to reach $16.2 billion by 2032, growing at an 8.4% CAGR
Osteoarthritis Therapeutics Market
According to Adroit Market Research Group, the global osteoarthritis treatments market was valued at $8.6 billion in 2023. The market is expected to grow at a compound annual growth rate (CAGR) of 8.4% from 2024 to 2032, reaching an estimated $16.2 billion.
This growth is driven by an aging population, increasing prevalence of osteoarthritis, and advancements in treatment options such as regenerative medicine and targeted therapies.
📌 Market Size (2023): $8.6 billion
📌 Projected Growth: 8.4% CAGR (2024-2032)
📈 Estimated Market Size (2032): $16.2 billion
Free Sample Report + All Related Graphs & Charts @ https://www.adroitmarketresearch.com/contacts/request-sample/5037
Comprehensive Analysis of the Global Osteoarthritis Therapeutics Market
The extensive examination of the global Osteoarthritis Therapeutics Market delves into the profiles of key supplier companies. Analysts highlight that this detailed documentation stems from rigorous research initiatives and the aggregation of evaluations across various pivotal factors that are progressively shaping the growth of the international Osteoarthritis Therapeutics sector. The study segments leading global manufacturers based on metrics such as sales, revenue, and, where pertinent, pricing strategies. Its main aim is to provide both qualitative and quantitative perspectives of the industry across different geographic regions and countries.
The enforcement of strict lockdown measures to mitigate the COVID-19 pandemic has significantly disrupted supply and demand patterns, impacting numerous businesses worldwide. Beyond the immediate fluctuations in short-term market profitability, it is anticipated that certain segments will encounter substantial challenges even as the global economy recovers from the pandemic. Essentially, nearly every business across various sectors has recalibrated their financial strategies to secure profitability in the upcoming years.
Moreover, the research evaluates regional growth rates, overall market size, expenditure data, and profitability analyses. A comprehensive assessment of competitive dynamics is included to furnish a substantial competitive advantage. Geographic analysis has been performed based on market share, projected growth, and key countries. A select group of major corporations commands a significant portion of this market. Competition within the global Osteoarthritis Therapeutics industry is intensifying as leading companies vie to surpass each other. The report encompasses detailed revenue analyses, methodologies employed, product specifications, and profiles of significant market players.
To achieve optimal outcomes, essential market strategies are reviewed from both technological and commercial perspectives. Additionally, consumers can benefit from in-depth market research by gaining a better understanding of the analysis and accessing relevant data. The study offers readers a broad overview of the industry, assisting them in comprehending the competitive landscape of the international Osteoarthritis Therapeutics Market.
Key Highlights of the Report:
• Identifies numerous lucrative opportunities for major industry players.
• Provides clients with measurable insights into the current market conditions.
• Includes strategic business plans of key market competitors.
• Presents a thorough examination of the target market, highlighting factors such as drivers, opportunities, and threats.
• Equips stakeholders with information to make informed investment decisions.
• Offers a market overview, encompassing key drivers and risk factors.
Buy the Complete Report with an Impressive Discount @ https://www.adroitmarketresearch.com/researchreport/purchase/5037
Reasons to Purchase This Report:
• The global Osteoarthritis Therapeutics Market research study offers valuable insights into the number of prominent companies operating on an international scale.
• It includes comprehensive company financials, technological advancements, supply chain/value chain trends, and significant innovations and developments.
• The report details mergers, acquisitions, joint ventures, key focus areas, investments, and market presence.
• Provides essential information about the target market's revenue, growth rate, and industry share, along with details on current driving forces, macro trends, and restraints.
Osteoarthritis Therapeutics Market Competitive Landscape:
Prominent participants in the worldwide osteoarthritis therapeutics sector play a vital role in the creation and advancement of efficient treatment alternatives. They are involved in executing clinical trials and guaranteeing the accessibility of therapies. Additionally, these stakeholders pursue strategic alliances and marketing initiatives to enhance their market reach and facilitate patient access to their offerings.
Prominent companies in the osteoarthritis treatment sector comprise AbbVie Inc., Amgen Inc., Bayer AG, Biogen Inc., the Celgene Corporation (part of Bristol-Myers Squibb), Horizon Therapeutics plc, Johnson & Johnson, Merck & Co., Inc., Novartis AG, Pfizer Inc., Regeneron Pharmaceuticals, Inc., Sanofi S.A., Stryker Corporation, Teva Pharmaceutical Industries Ltd., and UCB S.A.
Latest Trends and Innovation in the Global Osteoarthritis Therapeutics Market:
• In September 2023, Amgen announced the acquisition of Horizon Therapeutics for $28 billion, focusing on expanding its portfolio of innovative therapies for osteoarthritis and other autoimmune diseases. This acquisition allows Amgen to incorporate Horizon's experience in specialized treatments into its broader therapeutic strategies.
• In July 2023, Pfizer revealed positive results from a Phase 3 clinical trial for its investigational drug, tanezumab, which is aimed at treating pain related to osteoarthritis. The trial demonstrated significant pain relief and functional improvement, prompting discussions about a potential submission for regulatory approval by the end of 2023.
• In August 2023, Eli Lilly and Company introduced a new formulation of its joint-therapy product, which utilizes an advanced drug delivery system designed to enhance the efficacy of osteoarthritis treatments. This innovation aims to improve patient compliance and outcomes.
• In June 2023, GSK (GlaxoSmithKline) filed for FDA approval of its monoclonal antibody targeting the nerve growth factor (NGF) involved in pain signaling in osteoarthritis. This novel therapy represents a significant step in the development of more targeted pain relief options for patients.
• In May 2023, Regeneron Pharmaceuticals announced a partnership with Sanofi to collaboratively develop new biologic therapies for osteoarthritis, combining their expertise in monoclonal antibodies to address inflammatory pathways involved in joint degeneration.
• In April 2023, Merck & Co. completed the acquisition of Pandion Therapeutics for $1.85 billion, signaling its commitment to developing innovative treatments for inflammatory diseases, including potential applications for osteoarthritis therapies.
• In March 2023, Novartis reported progress in its research on gene therapies targeting cartilage degradation in osteoarthritis, with early-stage trials showing promising results in restoring joint function and halting disease progression.
Access Full Reports @ https://www.adroitmarketresearch.com/industry-reports/osteoarthritis-therapeutics-market
Segments of the Osteoarthritis Therapeutics Market
By Type
• Hip Osteoarthritis
• Spinal Osteoarthritis
• Knee Osteoarthritis
• Hand Osteoarthritis
• Others
By Drug Class
• Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
• Other Analgesics
• Corticosteroids
• Hyaluronic Acid Injections
• Others
By Doses Form
• Tablets and Capsules
• Injections
• Creams and Gels
• Others
By Route of Administration
• Oral
• Parenteral
• Topical
By End User
• Hospitals
• Specialty Clinics
• Homecare Settings
• Others
Regional Overview
• North America
• Europe
• Asia Pacific
• Middle East and Africa
• Latin America
Top Trending Reports:
Cancer Biological Therapy Market: https://www.adroitmarketresearch.com/industry-reports/cancer-biological-therapy-market
Hepatitis Therapeutics Market: https://www.adroitmarketresearch.com/industry-reports/hepatitis-therapeutics-market
Osteoarthritis Therapeutics Market: https://www.adroitmarketresearch.com/industry-reports/osteoarthritis-therapeutics-market
Cell Therapy Market: https://www.adroitmarketresearch.com/industry-reports/cell-therapy-market
Antibody Therapeutics and Blood Antibody Therapeutics Market: https://www.adroitmarketresearch.com/industry-reports/antibody-therapeutics-and-blood-antibody-therapeutics-market
CONTACT US:
Ryan Johnson
Account Manager Global
3131 McKinney Ave Ste 600, Dallas,
TX 75204, U.S.A
Phone No.: USA: +1 9726644514
ABOUT US:
Adroit Market Research is an India-based business analytics and consulting company. Our target audience is a wide range of corporations, manufacturing companies, product/technology development institutions and industry associations that require understanding of a markets size, key trends, participants and future outlook of an industry. We intend to become our clients knowledge partner and provide them with valuable market insights to help create opportunities that increase their revenues. We follow a code- Explore, Learn and Transform. At our core, we are curious people who love to identify and understand industry patterns, create an insightful study around our findings and churn out money-making roadmaps.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Osteoarthritis Therapeutics Market was valued at $8.6 billion in 2023 and is projected to reach $16.2 billion by 2032, growing at an 8.4% CAGR here
News-ID: 3907442 • Views: …
More Releases from Adroit Market Research
Electronic Health Records Market Estimated Size Valuation will be USD 47.62 Bill …
The global Electronic Health Records market reached a value of US$ 30.65 Billion in 2023 and is expected to reach US$ 47.62 Billion by 2032, exhibiting a CAGR of 6.01% during the prediction period of 2023 to 2032.
Executive Synopsis:
The last few years have seen a notable increase in the global Electronic Health Records market because of technological breakthroughs, rising demand from a variety of industries, and continuous R&D initiatives to…
Organic Food Market Size to Reach USD 525.65 Billion at a CAGR of 12.09% by 2032 …
The global Organic Food market reached a value of US$ 170.05 Billion in 2023 and is expected to reach US$ 525.65 Billion by 2032, exhibiting a CAGR of 12.09% during the prediction period of 2023 to 2032.
The global Organic Food market report uses methods and major market analysis
To give a thorough picture of the market, the global Organic Food market report uses a range of analytical techniques and frameworks. Market…
Quantum Computing Market Size to Grow Worth USD 888.5 Million at a CAGR of 33.10 …
The global Quantum Computing market reached a value of US$ 888.5 Million in 2023 and is expected to reach US$ 12,622.9 Million by 2032, exhibiting a CAGR of 33.10% during the prediction period of 2023 to 2032.
What is said in the market report for global Quantum Computing
A thorough examination of the market's structure, trends, obstacles, and opportunities is included in the global Quantum Computing market study. A thorough analysis of…
Software as a Service Market Size to grow USD 1,230.81 Billion by 2032 | CAGR of …
The global Software as a Service market reached a value of US$ 275.53 Billion in 2023 and is expected to reach US$ 1,230.81 Billion by 2032, exhibiting a CAGR of 19.5% during the prediction period of 2023 to 2032.
Extensive Assessment of COVID-19's Impact on the Worldwide Software as a Service Industry
The COVID-19 pandemic had a substantial effect on the global Software as a Service market, altering market dynamics through supply…
More Releases for Osteoarthritis
Osteoarthritis Market Massive Growth opportunity Ahead
Introduction
Osteoarthritis (OA), the most common form of arthritis, remains a significant global health burden, causing pain, mobility limitations, and reduced quality of life for millions. Driven by an aging population, lifestyle-related factors like obesity, and a growing focus on musculoskeletal health, the osteoarthritis market is witnessing notable transformation.
According to Exactitude Consultancy, the global osteoarthritis market was valued at USD 14 billion in 2024 and is projected to reach USD 22…
Rising Sports Injuries Fuel Growth In Osteoarthritis Therapeutics Market: The Dr …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Osteoarthritis Therapeutics Market Size Growth Forecast: What to Expect by 2025?
In recent times, the osteoarthritis therapeutics market has seen substantial growth. The market size was $8.17 billion in 2024 and is projected to rise to $8.87 billion in 2025, reflecting an annual compound growth rate (CAGR) of 8.6%.…
Osteoarthritis Treatment Market Trends and Forecast 2034
On March 20, 2025, Exactitude Consultancy., Ltd. announces the release of the report "Global Osteoarthritis Treatment Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2034". The report is a detailed and comprehensive analysis presented by region and country, type and application. As the market is constantly changing, the report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across…
Osteoarthritis Treatment Market
Introduction
Osteoarthritis (OA) is the most common form of arthritis, affecting millions worldwide. It is a degenerative joint disease that primarily impacts the cartilage and causes pain, stiffness, and reduced mobility. The growing prevalence of osteoarthritis, especially among the aging population, has created a significant demand for treatment options. The osteoarthritis treatment market includes various therapeutic approaches, such as medications, physical therapies, and surgical procedures, designed to manage the symptoms and…
Osteoarthritis Therapeutics Market - Finding Freedom from Osteoarthritis: Discov …
Newark, New Castle, USA: The "Osteoarthritis Therapeutics Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Osteoarthritis Therapeutics Market: https://www.growthplusreports.com/report/osteoarthritis-therapeutics-market/7779
This latest report researches the industry structure, sales, revenue,…
Osteoarthritis Therapeutics Market: Rising Obese and Geriatric Populations to In …
Industry is experiencing significant growth due to the rapid growth in the geriatric and obese population and the associated increase in the prevalence of osteoarthritis disease. Risk of adverse cardiovascular events associated with the use of NSAIDs in osteoarthritis treatment is likely to hamper the growth of the market.
What the Osteoarthritis Therapeutics Market Looks Like?
The osteoarthritis therapeutics market is projected to reach USD 10.1 billion by 2024 from USD 6.8…
